DOSSIER · UPDATED 18 NOV 2025

HilleVax

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.

hillevax.com ↗Claim this profile

Founded: 2021
Headcount: 83
Open roles: 0
Last raised: Post Ipo Equity · $100M

SECTION I · THE BRIEF

Inside HilleVax

Brief #50791Updated 18 NOV 2025BOSTONLIGHTSPEED VENTURE PARTNERSPOST IPO EQUITY

Employbl Dossier

HilleVax

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.

Founded: 2021
Headcount: 83
Open roles: 0
Last raised: Post Ipo Equity · $100M

Section II · Premium ProfileMembers only

01Engineering interview process at HilleVaxLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open HilleVax brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Aditya Kohli

David Socks

Robert Hershberg

OPEN ROLES

Hiring at HilleVax

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $235,000,000

HilleVax's Investors

Lightspeed Venture Partners

HilleVax Funding Rounds

Post Ipo Equity
$100,000,000
Sep 19, 2023
Post Ipo Equity
$100,000,000
Sep 18, 2023
IPO
Unknown
Apr 29, 2022
IPO
Unknown
Jan 1, 2022
Series Unknown
$135,000,000
Sep 8, 2021
Series Unknown
$135,000,000
Sep 7, 2021
Series Unknown Investors
Frazier Management
Sahsen Ventures
Catalys Pacific
Samsara BioCapital
Lightspeed Venture Partners
BVF Partners
Perceptive Advisors
Qiming Venture Partners USA
Richard King Mellon Foundation
RA Capital Management
Greenspring Associates
Abingworth
Deerfield Management